US2023372229A1PendingUtilityA1

Producing a topical solution composition

Assignee: SHANTEL MEDICAL SUPPLY CORPPriority: Aug 13, 2007Filed: Apr 24, 2023Published: Nov 23, 2023
Est. expiryAug 13, 2027(~1 yrs left)· nominal 20-yr term from priority
Inventors:Kay Liu
A61K 8/96A61Q 19/02A61K 8/347A61K 8/678A61K 8/9789A61K 8/673A61K 8/06A61K 2800/85
67
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The appearance of hyperpigmented lesions on human skin are reduced by applying a topical solution composition that includes a concentrated amount of resveratrol that has been extracted from red wine and is at a pH of between 2.5 and 5.5.

Claims

exact text as granted — not AI-modified
1 - 37 . (canceled) 
     
     
         38 . A topical solution composition comprising:
 a red wine extract present in an amount ranging from 1.0 to 50.0 weight percent based on a total weight of the topical solution composition, the red wine extract comprising resveratrol;   water; and   vitamins, wherein the vitamins are present in the topical solution composition in an amount that is sufficient to provide the topical solution composition with a pH ranging from 2.5 to 5.5.   
     
     
         39 . The topical solution composition of  claim 38 , wherein the topical solution composition exhibits the capability of reducing the number of visible lesions on human skin. 
     
     
         40 . The topical solution composition of  claim 38 , wherein the resveratrol comprises cis- and trans-resveratrol. 
     
     
         41 . The topical solution composition of  claim 38 , further comprising an emulsifier. 
     
     
         42 . The topical solution composition of  claim 41 , wherein the emulsifier comprises a carbomer base. 
     
     
         43 . The topical solution composition of  claim 38 , wherein the red wine extract is an extract of fermented grapes having concentrations of resveratrol. 
     
     
         44 . The topical solution composition of  claim 43 , wherein the red wine extract has an amount of alcohol of no more than 2 percent by volume. 
     
     
         45 . The topical solution composition of  claim 44 , wherein the red wine extract is an extract from grapes fermented by use of yeast as an agent for a duration of between seven days and forty-five days, at a temperature between 35 degrees F. and 95 degrees F., and at a humidity between 30 percent and 80 percent. 
     
     
         46 . The topical solution composition of  claim 38 , wherein the red wine extract is extracted from magenta-colored red wine grapes. 
     
     
         47 . The topical solution composition of  claim 38 , wherein the red wine extract is extracted from merlot grapes, cabernet grapes, or combinations thereof. 
     
     
         48 . The topical solution composition of  claim 38 , wherein the red wine extract is in powder form. 
     
     
         49 . The topical solution composition of  claim 38 , wherein the vitamins comprise vitamin B5, vitamin E, or combinations thereof. 
     
     
         50 . The topical solution composition of  claim 38 , wherein the topical solution composition is in the form of the topical gel. 
     
     
         51 . The topical solution composition of  claim 50 , wherein the topical solution composition comprises  Aloe barbendesis  leaf juice, cucumber extract, hyaluronic acid, isoprene glycol, tocopherol acetate (Vitamin E), chamomile extract, jojoba oil, hydrolyzed silk protein, nettle extract, hydrolyzed wheat protein, phytic acid, wheat germ oil, horsetail extract,  Centella asiatica  extract,  Chlorella vulgaris  extract, hydrolyzed align, butylene glycol, D-Panthenol (Vitamin B5), caffeine extract, carbomer, phenoxyethanol, methylparaben, butylparaben, ethylparaben, propylparaben, triethanolamine, or combinations thereof. 
     
     
         52 . The topical solution composition of  claim 50 , wherein the topical solution composition comprises Carbomer, Isoprene Glycol, Xanthan Gum, Butylene Glycol, or combinations thereof. 
     
     
         53 . The topical solution composition of  claim 38 , wherein the topical solution composition is in the form of the topical cream. 
     
     
         54 . The topical solution composition of  claim 53 , wherein the topical solution composition comprises isoprene glycol, dimethicone, dimethylpolysiloxane, squalane, chinesis seed oil, tetrahexyldecyl ascorbate (Vitamin C), tocopherol acetate (Vitamin E), panthenol (Vitamin B5), cetyl alcohol, shea butter, bees wax, cetearyl glycoside, xanthan gum, carbomer,  Santalum album  (sandalwood) extract,  Phellodendron amurense  bark extract,  Hordeum distichon  (barley) extract, phenoxyethanol, methylparaben, propylparaben, butylparaben, or combinations thereof. 
     
     
         55 . The topical solution composition of  claim 53 , wherein the topical solution composition comprises Isoprene Glycol, Polyglyceryl-2 Stearate, Dimethylpolysiloxane Cetyl Alcohol, Bees Wax, Cetearyl Glucoside, Xanthan Gum, Carbomer, or combinations thereof. 
     
     
         56 . A topical solution composition comprising:
 a red wine extract present in an amount ranging from 1.0 to 50.0 weight percent based on a total weight of the topical solution composition, the red wine extract comprising resveratrol;   water;   an emulsifier;   vitamins, wherein the vitamins are present in the topical solution composition in an amount that is sufficient to provide the topical solution composition with a pH ranging from 2.5 to 5.5;   wherein the topical solution composition is in the form of a topical gel or a topical cream; and   wherein the topical solution composition exhibits the capability of reducing the number of visible lesions on human skin.   
     
     
         57 . A topical solution composition comprising:
 a red wine extract present in an amount ranging from 1.0 to 50.0 weight percent based on a total weight of the topical solution composition, the red wine extract comprising resveratrol;   water;   an emulsifier;   vitamins, wherein the vitamins are present in the topical solution composition in an amount that is sufficient to provide the topical solution composition with a pH ranging from 2.5 to 5.5;   wherein the topical solution composition exhibits the capability of reducing the number of visible lesions on human skin.

Join the waitlist — get patent alerts

Track US2023372229A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.